메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's Disease Research

FREMONT, Calif., Jan. 13, 2026 -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) NULISAqpcr™ AD 5-plex Assay. This innovative solution enables simultaneous quantitative measurement of five critical blood-based biomarkers relevant to the Alzheimer's Association recommended guidelines: brain-derived phosphorylated tau 217 (BD-pTau217), neurofilament light chain (NfL), amyloid-beta 42 (Aβ42), glial fibrillary acidic protein (GFAP), and APOE4 (carr
- 김갑성 기자
- 2026-01-13 06:27
"IN SNOOKI WE TRUST" - NICOLE 'SNOOKI' POLIZZI HEADS NORTH IN NEW SERIES, CANADA SHORE

CANADA SHORE premieres January 22 with two back-to-back episodes on Paramount+ Check out the CANADA SHORE "This Season On" Trailer HERE Follow @CANADASHORE on INSTAGRAM and TIKTOK for the Latest News, Exclusive Content and more Snooki Images HEREKey Art, Promo Trailer and Cast Images HEREPhoto credit Paramount+ TORONTO, Jan. 13, 2026 -- Paramount+ announced today that the legendary JERSEY SHORE original cast member Nicole 'Snooki' Polizzi will bring her small stature and big personality to the Shore house, making several powerhouse guest appeara
- 김장윤(JASON KIM) 기자
- 2026-01-13 03:29
HCLTech Q3 FY26 revenue up 4.2% QoQ (CC) as annualized revenue crosses $15B; bookings exceptionally high at $3B

Revenue guidance raised to 4.0% - 4.5% YoY CC, services revenue guidance to 4.75%-5.25% YoY CC NEW YORK and NOIDA, India, Jan. 13, 2026 -- HCLTech (NSE: HCLTECH.NS) (BSE: HCLTECH.BO), a leading global technology company, delivered a strong performance for the quarter ended December 31, 2025, with USD revenue at $3.8 billion. The revenue in constant currency (CC) increased 4.2% QoQ and 4.8% YoY. "(We had) another standout quarter on all fronts… with a strong recovery of operating margin to 18.6%. The strong revenue momentum in the quarter has enabled us to cross $15
- 황정호 기자
- 2026-01-13 02:27
diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy

[ 메디채널 김갑성 기자 ] Expert recommendations provide crucial guidance to leverage CGM and AID during pregnancy. SAN FRANCISCO, Jan. 13, 2026 -- The diaTribe Foundation announces the publication of the first international consensus statement on the use of continuous glucose monitoring (CGM) and automated insulin delivery (AID) during pregnancy. Published in The Lancet Diabetes & Endocrinology, the document aims to standardize care, improve outcomes, and ease the daily burden of managing type 1 (T1D), type 2 (T2D), and gestational diabetes (GDM) during pregnancy. Managing diabetes
- 김갑성 기자
- 2026-01-13 01:22
NVISAGE Technologies to Present Complete Golf Launch Monitor Lineup at PGA Show 2026

CHICAGO, Jan. 13, 2026 -- NVISAGE Technologies, a U.S.-based leader in next-generation golf technology, will showcase its full portfolio of golf launch monitors at PGA Show 2026, the industry's most influential golf trade event. The exhibition will take place from January 21–23, 2026, in Orlando, Florida, where attendees can explore NVISAGE's innovative golf technology at booth 1515. Founded in 2023 and headquartered in Illinois, NVISAGE Technologies has quickly established itself as a trusted name in indoor and outdoor golf solutions. The company's mission is to make a
- 황정호 기자
- 2026-01-13 00:00
Field Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

CARDIFF-BY-THE-SEA, Calif., Jan. 12, 2026 -- Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation (PFA) platform designed to support both ventricular tachycardia (VT) and atrial fibrillation (AF) ablation, today announced that its founder, Steven Mickelsen, MD, will present at the 44th annual J.P. Morgan Healthcare Conference on Thursday, Jan. 15, 2026, at 10 a.m. PT at The Westin St. Francis in San Francisco. The presentation will feature a company overview, including the FieldForce™ PFA platform,
- 김갑성 기자
- 2026-01-12 23:03
Suvoda sets new standard for streamlined patient and site experience in clinical trials

CONSHOHOCKEN, Pa., Jan. 12, 2026 -- Suvoda, a clinical trial technology company, took decisive steps in 2025 toward a more connected and streamlined clinical trial experience for both patients and sites. The company's merger with Greenphire marked a pivotal moment in that journey, strengthening Suvoda's ability to tackle persistent trial operational challenges with a more unified approach. Together with continued product innovation and deployment of AI tools, Suvoda closed the year with growing momentum toward a single, cohesive ecosystem that reduces complexity across the clinical tr
- 김장윤(JASON KIM) 기자
- 2026-01-12 23:00
Basecamp Research launches world-first AI models for programmable gene insertion

[ 메디채널 김갑성 기자 ] The breakthrough tackles a longstanding challenge in genetic medicine with the goal of developing a new generation of curative cell and gene therapies. Developed in collaboration with NVIDIA by training the largest evolutionary AI models on a new, globally collected dataset, accelerated by NVIDIA BioNeMo. The same versatile model also helped design novel antimicrobial peptide molecules with a 97% lab-confirmed success rate, including candidates that appeared highly potent against multidrug-resistant "superbugs." Basecamp Research also adds NVentures as an inve
- 김갑성 기자
- 2026-01-12 23:00
베이스캠프 리서치, 세계 최초 프로그램 가능한 유전자 삽입 AI 모델 출시

[ 메디채널 김갑성 기자 ] 세대 치료 세포 요법 및 유전자 요법 개발을 목표로 유전 의학 분야의 오랜 과제 해결 엔비디아(NVIDIA)와의 협업을 통해 전 세계에서 수집한 대규모 신규 데이터셋으로 최대 규모의 진화 AI 모델 학습 및 NVIDIA BioNeMo로 가속화 동일 모델을 통해 설계된 새로운 항균 펩타이드 분자, 다제내성 '슈퍼박테리아'에 강력한 효과를 보이며 실험실 검증 97%의 성공률 기록 에덴(EDEN) 모델에 대한 깊은 기술적 협력을 바탕으로 시리즈 C 라운드 전 엔벤처스(NVentures)로부터 투자 유치 런던 및 매사추세츠주 캠브리지, 2026년 1월 12일 -- 진화를 활용해 신약을 설계하는 프런티어 AI 연구소인 베이스캠프 리서치(Basecamp Research)가 1월 1일 프로그램 가능한 유전자를 삽입할 수 있는 최초의 AI 모델을 발표했다. 이는 결함이 있는 유전자를 교체하고 치료 목적으로 세포를 재프로그래밍하는 새로운 방식을 제시한다. 엔비디아와의 협력을 통해 학습된 이 모델들은 암 및 유전 질환에 대한 차세대 치료제 개발을 주도하고 있다. 이와 함께 베이스캠프 리서치는 수년간의 긴밀한 기술
- 김갑성 기자
- 2026-01-12 23:00
NYSE Content Advisory: Pre-Market Update + NYSE Takes Its Bell on the Road to JPMorgan's Healthcare Event

NEW YORK, Jan. 12, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + NYSE Takes Its Bell on the Road to JPMorgan’s Healthcare Event JD Durkin delivers the pre-market update on January 12th Stocks are down Monday morning after the Justice Department opened a criminal investigation into Federal Reserve Chair Jerome Powell. Despite White House pressure to lower interest
- 황정호 기자
- 2026-01-12 22:00

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2026-01-15_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 15일 15시 20분